NanoPin Technologies Founder's Study Demonstrates Greater Accuracy in Detecting TB in Infants
NanoPin Technologies Founder's Study Demonstrates Greater Accuracy in Detecting TB in Infants Advanced diagnostics designed to mitigate the enduring TB epidemic Accurate detection platform has applications for COVID-19, HIV, and other infectious diseases News provided by Share this article Share this article NEW ORLEANS, May 19, 2021 /PRNewswire/ -- NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by found...